The Epigenetic Paradigm Shift: Driving Therapeutic Advancements through Market Growth
The global epigenetics market is witnessing remarkable growth, poised to surge from $1.8 billion in 2023 to an impressive $4.3 billion by 2028, reflecting a robust compound annual growth rate (CAGR) of 18.3%. This burgeoning market is fueled by favorable government initiatives, substantial investment in epigenetic research, and an escalating demand for epigenetic-based therapeutics. At the heart of this growth lies the quest to unravel the intricate mechanisms governing gene expression and its pivotal role in a myriad of diseases, ranging from cancer and neurological disorders to autoimmune conditions. Pharmaceutical and biotechnology giants are channeling substantial resources to decipher the complexities of epigenetic processes, harnessing their therapeutic potential to revolutionize treatment paradigms. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=896 Notable players in this arena include industry titans such as Thermo Fisher Scientific, Il...